Physician profile

John K Anderson

Orthopaedic Surgery · Brighton, MI

NPI 1245377837

$7,725.18

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$197.22

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Arthrex, INC. $3,064.16 2019-2021
Smith+Nephew, INC. $2,082.33 2019-2022
Pinnacle, INC $1,210.21 2019-2024
Paragon 28, INC. $673.39 2022
Zimmer Biomet Holdings, INC. $280.07 2022
Medwest Associates $208.80 2021
Djo, LLC $171.40 2019-2023 Aircast, Donjoy
Bioventus LLC $17.49 2020
Stryker Corporation $17.33 2024 Mako

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John K Anderson

$7,725.18

in general payments reported 2019-2025

Years
2019-2024
Top company
Arthrex, INC.

https://glasscript.com/doctor/282944/john-k-anderson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.